pocketful logo
CARE Ratings Ltd logo

CARE Ratings Ltd

NSE: CARERATING BSE: 534804

1612.30

(-0.43%)

Tue, 03 Mar 2026, 00:17 pm

CARE Ratings Analysis

dividend

thumbs up icon

Pros

  • Dividends paid are covered by earnings (1.2x coverage).
  • Dividends after 3 years are expected to be covered by earnings (1.2x coverage).
  • CARE Ratings's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • CARE Ratings's dividend is above the markets top 25% of dividend payers in India (3.08%).
thumbs up icon

Cons

  • Dividend payments have increased, but CARE Ratings only paid a dividend in the past 7 years.
  • CARE Ratings has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).

future

thumbs up icon

Pros

  • Performance (ROE) is expected to be above the current IN Capital Markets industry average.
  • An improvement in CARE Ratings's performance (ROE) is expected over the next 3 years.
thumbs up icon

Cons

  • Cash flow for CARE Ratings is expected to decrease over the next 2 years.
  • CARE Ratings's earnings are expected to grow by 4.2% yearly, however this is not considered high growth (20% yearly).
  • CARE Ratings's earnings growth is positive but not above the India market average.
  • CARE Ratings's earnings growth is positive but not above the low risk savings rate of 7.2%.
  • CARE Ratings's earnings are expected to increase but not above the low risk growth rate next year.
  • CARE Ratings's net income is expected to increase but not above the 50% threshold in 2 years time.
  • CARE Ratings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
  • CARE Ratings's revenue is expected to increase but not above the 50% threshold in 2 years time.
  • CARE Ratings's revenue is expected to grow by 3.3% yearly, however this is not considered high growth (20% yearly).
  • CARE Ratings's revenue growth is positive but not above the India market average.

health

thumbs up icon

Pros

  • CARE Ratings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • CARE Ratings is profitable, therefore cash runway is not a concern.
  • CARE Ratings is profitable, therefore cash runway is not a concern.
  • CARE Ratings has no debt, it does not need to be covered by operating cash flow.
  • CARE Ratings has no debt, it does not need to be covered by short term assets.
  • CARE Ratings's cash and other short term assets cover its long term commitments.
  • CARE Ratings has not taken on any debt in the past 5 years.
  • CARE Ratings has no debt, therefore coverage of interest payments is not a concern.
  • CARE Ratings has no debt.
  • Low level of unsold assets.
thumbs up icon

Cons

    management

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • The average tenure for the CARE Ratings board of directors is less than 3 years, this suggests a new board.
      • The average tenure for the CARE Ratings management team is less than 2 years, this suggests a new team.

      misc

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • CARE Ratings is covered by less than 3 analysts.
        • CARE Ratings has significant price volatility in the past 3 months.

        past

        thumbs up icon

        Pros

        • CARE Ratings used its assets more efficiently than the IN Capital Markets industry average last year based on Return on Assets.
        thumbs up icon

        Cons

        • CARE Ratings's 1-year earnings growth is negative, it can't be compared to the 5-year average.
        • CARE Ratings's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
        • CARE Ratings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
        • CARE Ratings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
        • CARE Ratings's 1-year earnings growth is negative, it can't be compared to the IN Capital Markets industry average.

        value

        thumbs up icon

        Pros

          thumbs up icon

          Cons

          • CARE Ratings's share price is below the future cash flow value, but not at a moderate discount (< 20%).
          • CARE Ratings's share price is below the future cash flow value, but not at a substantial discount (< 40%).
          • CARE Ratings is overvalued based on assets compared to the IN Capital Markets industry average.
          • CARE Ratings is poor value based on expected growth next year.
          • CARE Ratings is overvalued based on earnings compared to the IN Capital Markets industry average.
          • CARE Ratings is overvalued based on earnings compared to the India market.
          • 534804 underperformed the Capital Markets industry which returned -21% over the past year.
          • 534804 underperformed the Market in India which returned -14.5% over the past year.
          • BSE:534804 is up 5.3% underperforming the Capital Markets industry which returned 8.7% over the past month.
          • BSE:534804 is up 5.3% underperforming the market in India which returned 8% over the past month.

          Open Your Free Demat Account Now!

          Step into a world of zero fees and limitless opportunities!

          pocketful logo

          2022-25 Pocketful. All rights reserved, Built with in India

          Version -5.76

          app image 1app image 2

          Explore

          Calculatorsfooter arrow down icon
          Popular Calculatorsfooter arrow down icon
          Group Stocksfooter arrow down icon

          Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800